Diaceutics Revenue and Competitors

Claim your profile

Parsippany, NJ USA



Total Funding



Estimated Revenue & Valuation

  • Diaceutics's estimated annual revenue is currently $30.6M per year.(i)
  • Diaceutics received $5.0M in venture funding in April 2018.
  • Diaceutics's estimated revenue per employee is $172,610
  • Diaceutics's total funding is $10.6M.

Employee Data

  • Diaceutics has 177 Employees.(i)
  • Diaceutics grew their employee count by 13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Diaceutics is the diagnostic development and commercialization service provider. We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network. Our ultimate goal is to drive better testing to enable better treatment decisions for patients.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Diaceutics News

2022-04-06 - Have Insiders Sold Diaceutics PLC (LON:DXRX) Shares Recently?

The Last 12 Months Of Insider Transactions At Diaceutics. In fact, the recent sale by Executive Officer Philip White was not their only sale of...

2022-03-22 - Diaceutics hopes to 'super charge' its offering in US market ...

Irish data analytics company Diaceutics has been approved by the Centres for Medicare and Medicaid Services (CMS) to receive data on US...

2020-08-26 - Belfast-based Diaceutics raises £4 million to speed up diagnostic testing for new drugs

Diaceutics, a Belfast-based data analytics company working in precision medicine diagnostics, has raised £4 million from Silicon Valley Bank’s UK Branch (SVB). Following a three year plan, the working capital will fuel global expansion and product development, particularly the startup’s DXRX pla ...

2019-09-08 - Diaceutics Maiden Loss Deepens On Listing Costs; Revenue ...

(Alliance News) - Pharmaceuticals-focused data analytics firm Diaceutics PLC said Monday its maiden interim loss deepened amid listing costs ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Diaceutics Funding

DateAmountRoundLead InvestorsReference
2018-04-06$5.0MUndisclosedWhiteRock Capital PartnersArticle